Australian biotech market today 02.04.09
Thursday, 02 April, 2009
Healthcare is up 2 per cent on a good day’s trading on the stock exchange at 1.30pm.
Pharmaxis (ASX:PXS) is up 11c, or 6.4 per cent, on yesterday’s news it had reached a critical milestone in its Phase III trail of Bronchitol in cystic fibrosis patients.
Mesoblast (ASX:MSB) is up 2.5 per cent on recent news it had raised over $10 million from private and sophisticated investors.
Cardiac catheter manufacturer CathRx (ASX:CXD) is up almost 13 per cent, while proteomics company Fluorotechnics (ASX:FLS) is down almost 20 per cent on very low volumes.
Pathology company Sonic Healthcare (ASX:SHL) is up 42c to $11.49.
Avita Medical (ASX:AVH) is up slightly on improved sales of its respiratory products Breath-A-Tech and Funhaler spacers.
Biota (ASX:BTA) is up 3c to 68c while CSL (ASX:CSL) is up almost 60c to0 $32.70.
Novogen (ASX:NRT) is up a touch, as is Phosphagenics (ASX:POH).
Scientists uncover how cancer cells hide from immune system
By targeting the RNA helicase known as DDX6, scientists could enable the immune system to...
Vanillin flavouring in vapes may disrupt embryo development
Vanillin — a common flavouring chemical in e-cigarettes — may disrupt the normal...
Heart valve tissues created from stem cells
The breakthrough should help advance our understanding into how human heart valves develop,...
